Turnes J, Oyagüez I, Planas R, García-Samaniego J, Diago M, Crespo J, Calleja JL, Solà R, Casado MA, Romero-Gómez M
Cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients
The Liver Meeting, AASLD’s 64th Annual Meeting in Washington, EEUU, 1-5 Noviembre 2013
Buti M, Gros B, Oyagüez I, Andrade RJ, Serra MA, Turnes J, Casado MA